Irl Greenwell to Class I Phosphatidylinositol 3-Kinases
This is a "connection" page, showing publications Irl Greenwell has written about Class I Phosphatidylinositol 3-Kinases.
Connection Strength
0.034
-
Clinical use of PI3K inhibitors in B-cell lymphoid malignancies: today and tomorrow. Expert Rev Anticancer Ther. 2017 Mar; 17(3):271-279.
Score: 0.034
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.